RGRakesh Ghimire

Rakesh Ghimire

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rakesh Ghimire has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antimicrobial resistance pattern of Shigella species isolated from human stool in Asia: A systematic review

    by Govinda Bhandari, Anush Acharya, Sudip Bastakoti, Rakesh Ghimire, Aarya Gnawali, Anupam Katuwal Chhetri, Akkal Giri

    Background: Shigella species are Gram-negative bacteria responsible for bacillary dysentery, particularly affecting children in low-income countries. The species are highly infectious and are primarily transmitted through contaminated food and water. Treatment typically involves antibiotics, but the rise of multidrug-resistant (MDR) Shigella strains has made management challenging. Methods: A comprehensive literature search was performed using PubMed and Google Scholar to identify studies on the prevalence of Shigella species and its antimicrobial resistance in Asia from 2000 to 2022. Results: The prevalence of Shigella varied widely, ranging from 1.31% to 40.34% in analysis of 25 studies. Among the four Shigella species, S. flexneri emerged as the most prevalent, accounting for 51.38% of isolates (n=6062/11797). S. boydii was the least encountered species, constituting only 1.5% of cases. Ampicillin resistance was high with rates exceeding 80% in eight studies. Tetracycline resistance exceeded 80% in nine out of 15 studies. Cotrimoxazole resistance was also very high with 15 studies showing rates over 80%. Chloramphenicol resistance was less common, with eight of 11 studies showing over 50% susceptibility. Gentamycin resistance was low, with 11 of 12 studies showing over 50% susceptibility. Ciprofloxacin low resistance with 100% susceptibility in five studies. Ceftriaxone resistance was also minimal. Conclusions: This systematic review highlights high burden of Shigella infection in Asia and significant drug resistance to tetracycline, ampicillin, nalidixic acid, and cotrimoxazole. Urgent actions include proper antibiotic use, and conducting clinical trials to develop effective management guidelines for Shigella infections is to be considered. KEYWORDS Shigella, human stool, antimicrobial resistance, asia

  • Public Understanding and Their Response to Covid-19 in Nepal: A Population Based Study

    by Rakesh Ghimire, Bidur Adhikari, Akritee Pokharel, Ranjeeta Subedi, Sujata Shakya, Anju Khapung, Shristi Kharel, Shital Bhandary, Pradip Gyanwali

    Introduction: : Corona Virus Disease (COVID-19) pandemic has become one of the major causes of death. Its prevention and control have been challenging for every nation. Public understanding and practice play vital roles in its containment. This study aimed at identifying public understanding and response to COVID-19 in Nepal. Method: : A population-based, cross-sectional study was conducted in Nepal among 3,582 adults through an online, self-administered questionnaire shared via Viber group created by Ministry of Health and Population. The outcome variables measured were knowledge, attitude and practice regarding COVID-19. The responses were analysed and predictors of response studied. Results: Most of the participants were male (73.2%), with mean age of 32.4 years. Majority were married (54.2%) and had knowledge about transmission and symptoms of COVID-19. Almost all (99.6%) stated that hand washing/sanitizing can prevent its transmission. However, myths about prevention like drinking hot water (78.9%), gargling (67.6%), avoiding imports (67.6%), distancing from pets (65.6%), and warm showers (40%) were prevalent. Most of the participants (98%) used mask. The average knowledge score was 9.74±1.59 out of 12, attitude score 7.09±0.77 out of 8, and practice score 2.70±0.53 out of 3. Majority supported the government’s efforts but were facing problems like difficulty getting daily consumables, increased levels of mental illnesses due to confinement, and facing increased economic burdens because of lockdown. Conclusion: From the findings, we can infer that government interventions should focus on minimizing the public’s difficulties due to lockdown while enforcing prevention strategies via raising awareness about COVID-19.

  • Open Access

    Challenges, progress, and opportunities in clinical toxicology in Nepal: a narrative review

    by Rakesh Ghimire, Rajesh Sharma, Sangha Ratna Bajracharya, Manish Yadav, Ziad Kazzi, Bibhav Acharya, Michael Eddleston, Ramu Kharel


  • Open Access

    Growing Need for Web-Based Simulation in Low and Middle-Income Countries: A Narrative Review

    by Rakesh Ghimire, Sanjeev Kharel, Subarna Giri, Allan J Hamilton

    Web-based simulation programs are poised to offer a productive means of delivering asynchronous training in healthcare professionals’ education. Similarly, web-based simulation programs could also sponsor specialty-specific, web-based fellowships for clinicians of low- and middle-income countries. Web-Based Simulation has been utilized for instruction in critical care fields such as emergency medicine and pediatric anesthesia. Studies have shown that enhanced self-reported knowledge and confidence have been achieved through tele simulation which is in line with in-person simulation. During the COVID-19 pandemic, simulations have helped clinicians hone their use of personal protective equipment and other infection control measures. Additionally, it has helped them in learning new and expanded roles, like processing equipment and assisting infected patients in prone position experiencing respiratory failure. However, web-based simulation programs also have unique challenges that must be satisfied: reliable broadband internet network access, multilingual capability, and programming quality. Studies indicate that cost-effective simulation training can be delivered to learners in remote, low-resource areas worldwide, including South Asia, where access to such education is limited. We aimed to explore the effectiveness, challenges, and strategies for implementing web-based simulation education in low- and middle-income countries, based on a thorough PubMed search focused on web-based simulation programs in medical education.


  • Open Access

    Anti-epileptic Drugs Use and Increased Risk of Stroke: A Systematic Review

    by Bikram Prasad Gajurel, Sanjeev Kharel, Riwaj Bhagat, Rakesh Ghimire, Kiran Bhusal, Divas Rijal

    Background: Antiepileptic drugs (AEDs), the predominant treatment for epilepsy, are also utilised for migraine, neuropathic pain, and bipolar disorders, accounting for 1% of usage among the common population. There is a greater risk of stroke, heart attack, and arrhythmia among AED users particularly those with enzyme-inducing properties. Summary: This systematic review aimed to look into the ischemic stroke risk among AED users, particularly in patients who had never had a cerebrovascular accident before. English-language literature was searched in the databases of PubMed, EMBASE, and Google Scholar between 2000 and 2021. Studies should report the association between AEDs and the ischemic stroke risk. The outcomes for assessing efficacy and safety were: event ratio, hazard ratio, odds ratio, and risk ratio. Seven of the eight studies showed an increased risk of ischemic stroke associated with AEDs among individuals without a history of cardiovascular accidents Phenytoin, sodium valproate, oxcarbamazepine, levetiracetam, phenobarbital, and carbamazepine were all linked to an increased risk of stroke. Adequate data on the association between the duration of AED exposure and stroke was missing. Key message: Not all AEDs are enzyme inducers. We conclude significant stroke risk with AEDs (mainly enzyme inducers), and dose dependency need to be assessed. The risks and benefits of AEDs should be weighed among the patients, especially with vascular risk factors to limit the risk of ischemic stroke.


  • Open Access

    Antiretroviral drug use and the risk of falls in people living with HIV: a systematic review and meta-analysis

    by Michail Koutentakis, Sushma Rathi, Ayomide Daniel Ode, Hirak Trivedi, Summiya Zafar, Pratima Lamichhane, Prahlad Gupta, Rakesh Ghimire

    Objective: The risk of falls in people living with HIV (PLHIVs) on antiretroviral therapy (ART) has received little attention in the literature. The aim of the meta-analysis is to quantify the association between fall risk and various categories of drugs used in ART. Material and Methods: PubMed, Google Scholar, Embase, and the Cochrane Central Register of Controlled Trials were systematically searched from inception to January 2023. Any observational study or controlled trial that reported on the relationship of at least one antiretroviral drug with falls in PLHIVs was included. Data on the frequency of single fallers, multiple fallers (≥2 falls), and non-fallers were extracted and studied for each drug and drug category. The pooled results were reported as an odds ratio (OR) with a 95% confidence interval (CI). Results: A total of five observational studies (51 675 participants) were included out of 414 articles obtained through a literature review. Stavudine use was found to be associated with an increased risk of single falls in PLHIVs (OR: 1.69, 95% CI: 1.08–2.66, P=0.02). However, efavirenz (OR: 0.82, 95% CI=0.76–0.89, PPP=0.37). Likewise, protease inhibitors, integrase inhibitors, nucleoside reverse transcriptase inhibitors, and non-nucleoside reverse transcriptase inhibitors were discovered to have no significant association with fall risk. Conclusion: Most drug categories of ART have no significant association with the risk of falls in PLHIVs. However, certain drugs, such as didanosine and stavudine, which have the inherent effect of causing balance deficits and neuropathy, should be used cautiously.

  • Open Access

    Pattern of Drug Information Sources Utilized by Medical Practitioners at A Teaching Hospital in Nepal

    by Pravin Prasad, Naresh Karki, Kamal Kandel, Shruti Shah, Vitasta Muskan, Rakesh Ghimire, Anis Mudvari, Pradip Gyanwali

    Introduction: The development of pharmaceutical industry has been adding new knowledge about drugs continuously making it difficult to remember each piece of information. The physicians need to be supplemented with new information using various unbiased and reliable drug information (DI) sources which will promote rationale use of medicines. This study aims to understand the commonly used sources of DI by prescribers at our institute, their usefulness and the need for an independent drug information unit at the institute. Methods: A cross-sectional descriptive study that included all prescribers presently working at this institute and actively involved in patient care was conducted. Consenting participants were requested to fill in the self-administered questionnaire. Data thus collected were entered using EpiData version 3.1 and were analysed using SPSS version 18. Results: Filled-in questionnaires were obtained from 147 prescribers. Almost all of the participants (95.80%) used textbooks and Online Medical Sites (OMS) as sources of DI. Among participants using OMS for DI, 80 (58.39%) classified them as sometimes biased. Less than half (41.25%) agreed that they will absolutely be benefitted from having unbiased DI services at the hospital. The participants most commonly (136, 92.50%) had queries related to dosage / administration on a daily basis. Conclusions: Most prescribers relied on textbooks and OMS for DI which in their opinion had some level of biasness associated with them. They also agreed on the need of independent DI services in the institution to support prescription practices.

  • Open Access

    Fear, Risk Perception, and Engagement in Preventive Behaviors for COVID-19 during Nationwide Lockdown in Nepal

    by Ashok Khanal, Sulochan Gc, Suresh Panthee, Atmika Paudel, Rakesh Ghimire, Garima Neupane, Amrit Gaire, Rukmini Sitaula, Suman Bhattarai, Shubhechchha Khadka, et al.

    The world has faced huge negative effects from the COVID-19 pandemic between early 2020 and late 2021. Each country has implemented a range of preventive measures to minimize the risk during the COVID-19 pandemic. This study assessed the COVID-19-related fear, risk perception, and preventative behavior during the nationwide lockdown due to COVID-19 in Nepal. In a cross-sectional study, conducted in mid-2021 during the nationwide lockdown in Nepal, a total of 1484 individuals completed measures on fear of COVID-19, COVID-19 risk perception, and preventive behavior. A multiple linear regression analysis was used to identify factors associated with COVID-19 fear. The results revealed significant differences in the fear of COVID-19 in association with the perceived risk of COVID-19 and preventive behaviors. Age, risk perception, preventive behavior, and poor health status were significantly positively related to fear of COVID-19. Perceived risk and preventive behaviors uniquely predicted fear of COVID-19 over and above the effects of socio-demographic variables. Being female and unmarried were the significant factors associated with fear of COVID-19 among study respondents. Higher risk perception, poor health status, and being female were strong factors of increased fear of COVID-19. Targeted interventions are essential to integrate community-level mental health care for COVID-19 resilience.


  • Open Access

    Potential Drug-drug Interaction among the Patients Admitted in Intensive Care Units of a Tertiary Care Centre: A Descriptive Cross-sectional Study

    by Rakesh Ghimire, Pravin Prasad, Subigya Parajuli, Rabin Basnet, Pratik Lamichhane, Nirmal Poudel, Pramesh Sunder Shrestha, Shristi Kharel, Akritee Pokharel, Anish Mudvari

    Introduction: Drug interactions are one of the major contributors to increase hospital stay, inflate health care expenses, and cause serious adverse events and end-organ damage. Patients admitted to the intensive care unit are already critically sick and are at greater risk of these adverse outcomes. The study aimed to find out the prevalence of potential drug-drug interactions in the Intensive Care Units of a tertiary care centre. Methods: A descriptive cross-sectional study was conducted among the patients admitted in the Intensive Care Unit of a tertiary care hospital from April-June 2019. Ethical approval was taken from the Institutional Review Board at the institute (Reference number: 399). Convenience sampling method was used. Data was collected using proforma and potential drug-drug interactions were identified using Lexicomp® drug-interactions version 1.1 (Wolters Kluwer). All the drug interactions identified were classified and the severity scale of interactions was also defined. Statistical Package for the Social Sciences version 17.0 was used for data analysis. Point estimate at 95% Confidence Interval was calculated along with frequency, percentage, mean, standard deviation, and mode. Results: Out of 101 patients, the prevalence of the drug-drug interaction was found to be 90 (89.11%) (83.04-95.18 at 95% Confidence Interval). A total of 490 drug-drug interactions were identified. In severity scale, it was seen that 311 (63.46%) were of moderate severity and 303 (61.83%) of drug interactions were categorised as category C in risk rating. Conclusions: Prevalence of potential drug-drug interactions was higher compared to similar published literature. The most common drug with potential interaction was fentanyl and among pairs was fentanyl plus paracetamol.


  • Open Access

    Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

    by Sanjeev Kharel, Suraj Shrestha, Rajeev Ojha, Neha Guragain, Rakesh Ghimire

    Background: Interleukin-6-receptor inhibitors like Tocilizumab and Satralizumab are showing promising results in the treatment of Neuromyelitis Optica spectrum disorder (NMOSD). We aimed to investigate the efficacy and safety of various Interleukin-6-receptor inhibitors in the management of NMO/NMOSD. Methods: PubMed, Embase, and The Cochrane Library were systematically searched for suitable studies. Change in Annualized Relapse Ratio (ARR), Change in Extended Disability Status Scale (EDSS) s, the proportion of relapse-free patients and proportion of patients with adverse events, including serious adverse events and mortality were the parameters considered for the meta-analysis for Tocilizumab. Mean difference (MD) with 95% CI was used to quantify the change in ARR and change in EDSS before and after treatment. A forest plot was prepared to indicate the efficacy and adverse effects outcomes. The results were compared with those of Satralizumab included in two trials. Results: A total of nine studies with 202 patients were included in our study. Tocilizumab found a good proportion (76.95% CI: 0.61–0.91; p < 0.001) of relapse free patients at follow up. It also significantly reduced mean ARR (mean difference: -2.6, 95% CI: − 2.71 to − 1.68; p < 0.001) and but did not show significant difference in change in EDSS score (mean difference = − 0.79, 95% CI: − 1.89 to − 0.31; p = 0.16). Also, the toxicity profile of Tocilizumab was acceptable considering the proportions of patients with adverse events 56% (95% C.I.;0.27–0.85, I2 = 88.95%, p < 0.001), proportions of patients with serious adverse events 11% (95% C.I.; 0.05 to 0.17, I2 = 0%, p < 0.001) and zero treatment related deaths. SAkura studies for Satralizumab showed similar relapse free patients (70% to 80%) and reduction of ARR and EDSS from baseline. Some studies of Tocilizumab have shown to reduce pain and fatigue while trials of Satralizumab had non-significant findings. Conclusion: Interleukin-6-receptor inhibitors therapy showed a promising result with good efficacy and acceptable adverse events profile for treatment of NMOSD.